The influence of subclinical hyperthyroidism on blood pressure, heart rate variability, and prevalence of arrhythmias

Thyroid

Volumn 22, Issue 5, 2012, Pages 454-460

  Kaminski, Grzegorz ^a   Makowski, Karol ^a   Michałkiewicz, Dariusz ^a   Kowal, Jarosław ^a   Ruchala, Marek ^b   Szczepanek, Ewelina ^b   Gielerak, Grzegorz ^a  

^a MILITARY INSTITUTE OF MEDICINE   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; RADIOACTIVE IODINE; THYROID HORMONE; THYROXINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; COMPARATIVE STUDY; DIASTOLIC BLOOD PRESSURE; EUTHYROIDISM; FEMALE; HEART ARRHYTHMIA; HEART RATE VARIABILITY; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; LIOTHYRONINE BLOOD LEVEL; MALE; PREVALENCE; PRIORITY JOURNAL; QT DISPERSION; SUBCLINICAL HYPERTHYROIDISM; SYSTOLIC BLOOD PRESSURE; THYROXINE BLOOD LEVEL;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DIASTOLE; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; HYPERTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PREVALENCE; THYROID GLAND; THYROTROPIN; TIME FACTORS; TRIIODOTHYRONINE;

EID: 84860484092     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2010.0333     Document Type: Article

References (25)

1. Koutras DA 1999 Subclinical hyperthyroidism. Thyroid 9:311-315.
2. Biondi B, Fazio S, Carella C, Sabatini D, Amato G, Cittadini A, Bellastella A, Lombardi G, Saccà L 1994 Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab 78:1028-1033.
3. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Saccà L, Filetti S, Lombardi G, Perticone F 2000 Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 85:4701-4705.
4. Mercuro G, Panzuto MG, Bina A, Leo M, Cabula R, Petrini L, Pigliaru F, Mariotti S 2000 Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropinsuppressive therapy with levothyroxine: effect of individual dose tailoring. J Clin Endocrinol Metab 85:159-164.
5. Iglesias P, Acosta M, Sanchez R, Fernández-Reyes MJ, Mon C, Díez JJ 2005 Ambulatory blood pressure monitoring in patients with hyperthyroidism before and after control of thyroid function. Clin Endocrinol (Oxf) 63:66-72.
6. Sgarbi JA, Villaca FG, Garbeline B, Villar HE, Romaldini JH 2003 The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. J Clin Endocrinol Metab 88:1672-1677.
7. Hegedus L, Faber J 1995 Calculation of the ideal dose of radioiodine for treatment of thyroid disease. Eur J Endocrinol 132:544-545.
8. -1997 The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 157:2413-2446.
9. Maestri R, Pinna GD 1998 POLYAN: a computer program for polyparametric analysis of cardio-respiratory variability signals. Comput Methods Programs Biomed 56:37-48.
10. Ching GW, Franklyn JA, Stallard TJ, Daykin J, Sheppard MC, Gammage MD 1996 Cardiac hypertrophy as a result of longterm thyroxine therapy and thyrotoxicosis. Heart 75:363-368.
11. Psaltopoulou T, Ilias I, Toumanidis S, Mantzou E, Marafellia P, Piperingos G, Koutras DA, Alevizaki M 2007 Endogenous subclinical hyperthyroidism: metabolic and cardiac parameters. Eur J Intern Med 18:423-429.
12. Biondi B, Fazio S, Palmieri EA, Tremalaterra R, Angellotti G, Bonè F, Riccio G, Cittadini A, Lombardi G, Saccà L 1999 [Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function]. Cardiologia 44:443-449.
13. Mancia G, Parati G 2000 Ambulatory blood pressure monitoring and organ damage. Hypertension 36:894-900.
14. Mancia G, Parati G, Hennig M, Flatau B, Omboni S, Glavina F, Costa B, Scherz R, Bond G, Zanchetti A; ELSA Investigators 2001 Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 19:1981-1989.
15. Sesso HD, Stampfer MJ, Rosner B, Hennekens CH, Gaziano JM, Manson JE, Glynn RJ 2000 Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in Men. Hypertension 36:801-807.
16. Casu M, Cappi C, Patrone V, Repetto E, Giusti M, Minuto F, Murialdo G 2005 Sympatho-vagal control of heart rate variability in patients treatedwith suppressive doses of L-thyroxine for thyroid cancer. Eur J Endocrinol 152:819-824.
17. Shinar Z, Akselrod S, Dagan Y, Baharav A 2006 Autonomic changes during wake-sleep transition: A heart rate variability based approach. Auton Neurosci 130:17-27.
18. Faber J, Wiinberg N, Schifter S, Mehlsen J 2001 Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur J Endocrinol 145:391-396.
19. Belardinelli L, Shryock JC, Wu L, Song Y 2005 Use of preclinical assays to predict risk of drug-induced torsades de pointes. Heart Rhythm 2:S16-S22.
20. -1996 Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93: 1043-1065.
21. Dougherty CM, Burr RL 1992 Comparison of heart rate variability in survivors and nonsurvivors of sudden cardiac arrest. Am J Cardiol 70:441-448.
22. La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, Ferrari R, Franchini M, Gnemmi M, Opasich C, Riccardi PG, Traversi E, Cobelli F 2003 Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation 107:565-570.
23. Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ 1985 Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 248:H151-H153.
24. Osman F, Franklyn JA, Daykin J, Chowdhary S, Holder RL, Sheppard MC, Gammage MD 2004 Heart rate variability and turbulence in hyperthyroidism before, during, and after treatment. Am J Cardiol 94:465-469.
25. Petretta M, Bonaduce D, Spinelli L, Vicario ML, Nuzzo V, Marciano F, Camuso P, De Sanctis V, Lupoli G 2001 Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur J Endocrinol 145:691-696.